Replimune REPL
NASDAQ REPL
$11.70 +0.28 (+2.50%)
As of: Oct 21, 2026 · 2:11 PM EDT

Replimune (REPL) Other financing activities (2018 - 2020)

Updated

Replimune's Other financing activities came in at $795,000 for FY2021 (year ended Mar 31, 2021).

Analysis

Replimune (REPL) Other financing activities (2018 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.19 Bn 1,101.77 Bn 19.71 Bn
2 Johnson & Johnson 616.03 Bn 534.56 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 366.82 Bn 321.20 Bn 12.21 Bn
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 235.89 Bn 191.29 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.32 Bn 115.96 Bn 10.94 Bn
10 Replimune 1.13 Bn 76.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -895,000.00
Sep 30, 2020 100,000.00
Jun 30, 2020 -100,000.00
Sep 30, 2018 -1.96 Mn
Jun 30, 2018 -195,000.00
API Access

Replimune Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=REPL&period=max&api_key=YOUR_API_KEY